
Tazar 1.125 G Injection
Marketer
Lupin Ltd
Salt Composition
Piperacillin (1000mg) + Tazobactum (125mg)
Overview Tazar 1.125 G Injection
Tazar 1.125 G Injection combines two antibiotics to combat diverse bacterial infections by eliminating the infectious microorganisms. Administration is exclusively by a healthcare professional; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on illness severity, adhering precisely to the prescribed regimen. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions to your doctor, who may adjust the dosage or substitute the medication. While generally safe under medical supervision, its use during pregnancy and breastfeeding should be discussed with your physician.
Uses of Tazar 1.125 G Injection
Infections caused by bacteria
Major Benefits of Tazar 1.125 G Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Tazar 1.125 G Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazar 1.125 G Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tazar 1.125 G Injection works:
Tazar 1.125 G Injection combines Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby boosting Piperacillin's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Tazar 1.125 G Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Tazar 1.125 G is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or absent negative impacts on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Tazar 1.125 G Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, suggesting no infant harm.
DrivingCONSULT YOUR DOCTOR
The effect of Tazar 1.125 G Injection on driving ability is unknown. Refrain from operating a vehicle if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should receive Tazar 1.125 G Injection with careful monitoring. Dosage modification for Tazar 1.125 G Injection might be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Tazar 1.125 G Injection appears to pose minimal risk for individuals with hepatic impairment. Available evidence indicates that dosage modification for this medication may be unnecessary in such cases. However, physician consultation is recommended.
What if you forget to take Tazar 1.125 G Injection :
Omitting a scheduled dose of Tazar 1.125 G Injection necessitates contacting your physician.
Facts to Know About Tazar 1.125 G Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
